drugset

drugset / Trial / NCT00486200

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

NCT00486200 ↗

Phase 2 Completed 695 enrolled Astellas Pharma Inc

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.

Timeline

Start: 2007-06-21
Primary completion: 2008-08-12
Completion: 2008-08-12

Publications

Background Tyring S, Wald A, Zadeikis N, Dhadda S, Takenouchi K, Rorig R. ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study. J Infect Dis. 2012 Apr 1;205(7):1100-10. doi: 10.1093/infdis/jis019. Epub 2012 Feb 20.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Amenamevir	Small molecule	—	Oral
Comparator	Valacyclovir	Unknown	—	Oral

Indications